Illumina, Dana-Farber Cancer Institute, Eastman Kodak, Aperio Technologies | GenomeWeb

Illumina has received US Patent No. 7,033,754, "Decoding of array sensors with microspheres." The patent claims a substrate with discrete sites distributed on the surface of the substrate. The sites on the surface comprise a population of microspheres with at least a first and a second subpopulation, according to the patent's abstract. Each subpopulation includes a bioactive agent and an identifier-binding ligand that will bind a decoder-binding ligand to elucidate the identity of the bioactive agent, the abstract states.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.